hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Mexico: AIDS Healthcare Foundation launches campaign against Merck's steep AIDS drug prices

Get RSS feed of these results

All components of this story

29 May 2008

'Shame on Merck': Drug Giant Blasted for Steep AIDS Drug Prices in Mexico in New US Print Ad Campaign by AHF

Author: AIDS Healthcare Foundation [USA]

…AIDS Healthcare Foundation (AHF)… today unveiled a new print advertisement in an ongoing advocacy campaign criticizing drug giant Merck (known as Merck Sharp & Dohme in Mexico) for its steep AIDS drug pricing in Mexico and other so-called middle-income (MI) countries. The ad, headlined 'Shame on Merck,' will first appear in…a respected…daily newspaper in New Jersey near Merck's US corporate headquarters… Patricia Campos, M.D., AIDS Healthcare Foundation's Latin America Bureau Chief, who is based in Mexico [said]... "We strongly urge Merck to immediately set access prices for its drug Stocrin in Mexico equal to the lowest available price in other middle-income countries…"

Read the full post here

+ Español - Hide

Author: Alicia Yolanda Reyes, CIMAC [México]

Para que México siga sosteniendo la oferta de acceso universal a los medicamentos para combatir el Virus de Inmunodeficiencia Humana (VIH), debe negociar con las farmacéuticas para reducir el precio que paga por ellos, recomendó Michael Weinstein, presidente de AIDS Healthcare Foundation…En México, Bristol Meyers y Merck Sharp [parte de Merck] venden Reyataz y Stocrin cuatro veces más caro que en otros países de América latina...Señaló Weinstein que si bien México está considerado como un país de ingresos medios...es injusto que los laboratorios quieran vender al mismo precio que a países ricos.

🚫Read the full post here